臨床試験機器と補助ソリューションの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

臨床試験機器と補助ソリューション市場の世界需要は、2023年の31億米ドルから2032年には70億2,000万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは9.5%です。

臨床試験機器と補助ソリューションは、医学研究においてデータ収集や実験に利用されるツール、デバイス、サポートサービスを指します。これには、診断機器から検査機器まで多様な機器と、データ管理、ロジスティクス、規制遵守サポートなどの補助サービスが含まれます。これらのリソースは、製薬・医療研究において臨床試験を円滑かつ確実に実施するために不可欠です。

市場力学

臨床試験機器と補助ソリューション市場は、臨床試験件数の増加、医学研究の進歩、慢性疾患の有病率の上昇などの要因によって牽引されています。臨床試験の複雑化に伴い、データ管理ツール、ロジスティクス、ラボサービスなど、幅広い専門機器と補助サービスが必要とされています。精密医療と個別化治療の重視は、高度な臨床試験機器の需要をさらに押し上げます。医薬品開発プロセスを合理化するための規制支援やイニシアチブが市場開拓に貢献しています。さらに、医薬品開発業務受託機関（CRO）の拡大と臨床試験のグローバリゼーションが、包括的な機器と補助ソリューションの需要を後押しし、市場全体を牽引しています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、臨床試験機器と補助ソリューションの世界市場における各セグメントを包括的に評価することもできます。臨床試験機器と補助ソリューション業界の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

本セクションでは、国別と地域別のセグメントに関する詳細なデータを提供することで、各製品・サービスの対象層を特定し、今後のビジネスチャンスにつなげます。

製品別

• ソーシング（調達（機器、付属品）、レンタル（機器、付属品））
• サプライロジスティクス（輸送、梱包、その他）
• サービス（校正、機器サービス、その他）
• その他

フェーズ別

• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける臨床試験機器と補助ソリューション市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 臨床試験機器と補助ソリューション-産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 業界動向
• ポーターのファイブフォース分析
• 市場魅力度分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • 直接マーケティング
  • 間接マーケティング
  • マーケティングチャネル発展動向

第5章 臨床試験機器と補助ソリューションの世界市場分析：製品別

• 製品別概要
• 実績データと予測データ
• 製品別分析
• ソーシング（調達（機器、付属品）、レンタル（機器、付属品））
• サプライロジスティクス（輸送、梱包、その他）
• サービス（校正、機器サービス、その他）
• その他

第6章 臨床試験機器と補助ソリューションの世界市場分析：フェーズ別

• フェーズ別概要
• 実績データと予測データ
• フェーズ別分析
• フェーズI
• フェーズII
• フェーズIII
• フェーズIV

第7章 臨床試験機器と補助ソリューションの世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他の欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他のアジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他のラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ

第8章 臨床試験機器と補助ソリューション企業の競合情勢

• 臨床試験機器と補助ソリューション市場競争
• パートナーシップ/提携/合意
• 合併・買収
• 新製品の発売
• その他の開発

第9章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• Ancillare
• LP
• Imperial CRS Inc.
• Woodley Equipment Company Ltd.
• Thermo Fisher Scientific Inc.
• Parexel International（MA）Corporation
• Emsere（MediCapital Rent）
• Quipment SAS
• IRM
• Marken
• Myonex
• Yourway

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Market Sales by Geography (USD MN)
• Supply/Logistics (Transportation, Packaging, Others) Market Sales by Geography (USD MN)
• Service (Calibrations, Equipment Servicing, Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Phase (USD MN)
• Phase I Market Sales by Geography (USD MN)
• Phase II Market Sales by Geography (USD MN)
• Phase III Market Sales by Geography (USD MN)
• Phase IV Market Sales by Geography (USD MN)
• Global Clinical Trial Equipment & Ancillary Solutions Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Clinical Trial Equipment & Ancillary Solutions Report
• Market Research Process
• Market Research Methodology
• Global Clinical Trial Equipment & Ancillary Solutions Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Phase
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Market Sales by Geography (USD MN)
• Supply/Logistics (Transportation, Packaging, Others) Market Sales by Geography (USD MN)
• Service (Calibrations, Equipment Servicing, Others) Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Phase (USD MN)
• Phase I Market Sales by Geography (USD MN)
• Phase II Market Sales by Geography (USD MN)
• Phase III Market Sales by Geography (USD MN)
• Phase IV Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Clinical Trial Equipment & Ancillary Solutions Market is presumed to reach the market size of nearly USD 7.02 Billion by 2032 from USD 3.1 Billion in 2023 with a CAGR of 9.5% under the study period 2024 - 2032.

Clinical trial equipment and ancillary solutions refer to the tools, devices, and support services utilized in medical research studies to collect data and conduct experiments. This encompasses a diverse range of equipment, from diagnostic devices to laboratory instruments, along with ancillary services such as data management, logistics, and regulatory compliance support. These resources are vital for ensuring the smooth and reliable execution of clinical trials in pharmaceutical and healthcare research.

MARKET DYNAMICS

The clinical trial equipment and ancillary solutions market is driven by factors such as the increasing number of clinical trials, advancements in medical research, and the rising prevalence of chronic diseases. The growing complexity of clinical trials necessitates a wide range of specialized equipment and ancillary services, including data management tools, logistics, and laboratory services. The emphasis on precision medicine and personalized therapies further boosts the demand for advanced clinical trial equipment. Regulatory support and initiatives to streamline the drug development process contribute to market growth. Additionally, the expansion of contract research organizations (CROs) and the globalization of clinical trials fuel the demand for comprehensive equipment and ancillary solutions, driving the overall market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial equipment & ancillary solutions. The growth and trends of clinical trial equipment & ancillary solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical trial equipment & ancillary solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries))
• Supply/Logistics (Transportation, Packaging, Others)
• Service (Calibrations, Equipment Servicing, Others)
• Others

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Equipment & Ancillary Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Equipment & Ancillary Solutions market include Ancillare, LP, Imperial CRS, Inc., Woodley Equipment Company Ltd., Thermo Fisher Scientific, Inc., Parexel International (MA) Corporation, Emsere (MediCapital Rent), Quipment SAS, IRM, Marken, Myonex, Yourway. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Phase
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Historic and Forecast Sales by Regions
• 5.5 Supply/Logistics (Transportation, Packaging, Others) Historic and Forecast Sales by Regions
• 5.6 Service (Calibrations, Equipment Servicing, Others) Historic and Forecast Sales by Regions
• 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY PHASE

• 6.1 Overview by Phase
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Phase
• 6.4 Phase I Historic and Forecast Sales by Regions
• 6.5 Phase II Historic and Forecast Sales by Regions
• 6.6 Phase III Historic and Forecast Sales by Regions
• 6.7 Phase IV Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS COMPANIES

• 8.1. Clinical Trial Equipment & Ancillary Solutions Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Ancillare
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. LP
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Imperial CRS Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Woodley Equipment Company Ltd.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Thermo Fisher Scientific Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Parexel International (MA) Corporation
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Emsere (MediCapital Rent)
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Quipment SAS
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. IRM
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. Marken
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. Myonex
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments
• 9.14. Yourway
  • 9.14.1. Company Overview
  • 9.14.2. Company Revenue
  • 9.14.3. Products
  • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies